Stay updated with breaking news from Therapeutics Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Felix Biotechnology — a biopharmaceutical company focused on developing first-in-class, durable, antibacterial therapies to treat chronic...
/PRNewswire/ -- Felix Biotechnology — a biopharmaceutical company focused on developing first-in-class, durable, antibacterial therapies to treat chronic...
Harrington on Wednesday morning. Feb. 23, announced it is accepting letters of intent for the award, which 'offers successful applicants financial resources and expertise to advance their discoveries toward clinical trials.' Up to 12 Harrington Scholar-Innovators ultimately will be selected.
Cross-linked news, and information resources about H5N1 strain of bird Flu virus
/PRNewswire/ -- The "Bacterial Conjunctivitis (Ophthalmology) - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering. This...